GlassVC

Abingworth

Venture capital firm · Founded 1973 · London, United Kingdom · London ↗

Abingworth is a transatlantic life sciences investment firm founded in London in 1973. It invests across all stages of development - from start-ups to public companies - in biotechnology and healthcare across Europe and the US, pioneering approaches including Clinical Co-Development and Venture Investments in Public Equities (VIPEs). It was acquired by The Carlyle Group in August 2022.

Tier 1Basis: AUM of approximately $2B at the August 2022 Carlyle acquisition - tier_2 AUM $2B-$10B rule.

Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

This profile is unclaimed. Built from public sources. If you're a partner or employee at Abingworth, you can claim it.

Claim this profileHow claiming works

Key numbers

Assets under management

$2B

Latest fund

Abingworth Bioventures 8 (ABV 8)$465M · 2021

Funds

No public record

LAST CHECKED NOV 2026

Check size

$15M–$30M

Stages

SeedSeries ASeries BGrowth

Sectors

Life Sciences

FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG

Track record

Outcomes are recorded from public sources and attributed to the firm, not to individual partners. Shutdowns and write-offs are an ordinary part of venture investing; inclusion here is a record, not a judgment.

Hits

Track record

No outcomes recorded yet from public sources.

Misses

Track record

No outcomes recorded yet from public sources.

Partners 6

Reputation 1

No reputation score — basis not established for this firm.

Contact

Published sources only

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

SOURCE: FIRM WEBSITE, AS PUBLISHED 2

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Abingworth. Reviews come from founders whose identity and relationship have been verified.

Write the first review

Methodology

Tier basis — AUM of approximately $2B at the August 2022 Carlyle acquisition - tier_2 AUM $2B-$10B rule. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.

The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.

Source record 2

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Abingworth — provenance: GlassVC catalog census, November 2026

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Reputation

  2. [2]

    FIRM SITE · Abingworth — Firm website, as published by the firm

    LAST CHECKED NOV 2026 ↗

    ↩ cites: Website

PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026